​Innovation Highlight: Adaptyv Bio

​Adaptyv Bio is a biotechnology company focused on accelerating protein engineering by integrating computational design with rapid experimental validation. The company develops platforms that streamline the process from AI-driven protein design to laboratory testing, helping researchers and biotech teams iterate on protein designs faster and more efficiently.

​By combining advances in machine learning, automation, and high-throughput experimentation, Adaptyv aims to reduce the traditional bottlenecks between computational predictions and experimental verification. Their technologies support applications across therapeutics, enzymes, and synthetic biology, enabling researchers to move more quickly from in-silico design to functional proteins in the lab.

​During this innovation highlight, the team will present how Adaptyv’s platform helps bridge the gap between dry-lab protein design and wet-lab validation, an increasingly important challenge in modern protein engineering.

​Speaker Bio

​Tudor-Stefan Cotet

​Tudor-Stefan is a Protein Engineer at Adaptyv Bio in Lausanne, where he works on developing and applying technologies for next-generation protein engineering.

​He completed an MSc in Biotechnology at ETH Zürich and holds a BSc in Biological Sciences from Imperial College London. During his studies, Tudor gained research experience across several leading institutions, including the Max Planck Institute of Biochemistry and Imperial College London, working on topics related to protein design, structural bioinformatics, and synthetic biology.

​His work focuses on bridging computational protein design and experimental implementation, helping translate advances in protein engineering into practical tools and applications.